In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-23 of 23 for your search:
Drug:  recombinant interferon alfa-2b
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Natural history/Epidemiology
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: A6181203, DARENCA STUDY 2, NCT01339962
2.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: 9267-01, 2001-034, NCT00221702
3.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 65 and under
Sponsor: Other
Protocol IDs: 2005-001110-41, NCT00461747
4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: NCI
Protocol IDs: NCI-2009-00778, S0518, U10CA032102, SWOG-S0518, NCT00569127
5.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 00041, U01CA062505, P30CA033572, CHNMC-PHII-23, NCI-T99-0085, CDR0000068262, T99-0085, NCT00006384
6.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: A6181065, NCT00267748
7.

Phase: Phase II
Type: Treatment
Status: Temporarily closed
Age: Over 1
Sponsor: Other
Protocol IDs: 2219, NCT00548847
8.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 05-125, NCT00610857
9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: TORAVA, ET2007-035, NCT00619268
10.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: D0708, R01CA095648, NCT00913913
11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: not specified
Sponsor: Other
Protocol IDs: CASE2609, NCI-2010-00640, NCT01100528
12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CASE8805, NCI-2010-01390, NCT01158534
13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Not specified
Sponsor: Other
Protocol IDs: 464.05, NCT01276730
14.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00152, YALE HIC#27409, NCI-7317, CDR0000441640, 7317, NCT00217542
15.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000511743, UCSD-060199, PHARMION-UCSD-060199, NCT00398450
16.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-0354, NCT00629200
17.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: METRO1/IPC2005-001, NCT00908869
18.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2009-0124, NCT00970996
19.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CASE-CCF-7509, P30CA043703, CASE-CCF-1062, IRB 7059, NCT00311558
20.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CASE3Y06, P30CA043703, NCT00498979
21.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 12 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: OSU-07033, NCI-2011-03121, OSU-2007C0057, NCT00634127, NCT01460875
22.

Phase: No phase specified
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: P04600, NCT00723710
23.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: EPROST-20070805, SCCC-2007055, NCT00854581
New Search